Federation des caisses Desjardins du Quebec’s Milestone Pharmaceuticals MIST Stock Holding History

Federation des caisses Desjardins du Quebec’s Portfolio MIST Stock Details MIST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$39.9K	Hold	29,781	–	–	﹤0.01%	1984
2026 Q1	$35.4K	Hold	29,781	–	–	﹤0.01%	1958
2025 Q4	$60.2K	Hold	29,781	–	–	﹤0.01%	1779
2025 Q3	$59.6K	Buy	29,781 +16,781	+129%	+$29.5K	﹤0.01%	1772
2025 Q2	$25.2K	Hold	13,000	–	–	﹤0.01%	1745
2025 Q1	$10.4K	Hold	13,000	–	–	﹤0.01%	1951
2024 Q4	$30.7K	Buy	13,000 +2,500	+24%	+$4.29K	﹤0.01%	1540
2024 Q3	$16K	Hold	10,500	–	–	﹤0.01%	1731
2024 Q2	$13.9K	Hold	10,500	–	–	﹤0.01%	1718
2024 Q1	$18.8K	Hold	10,500	–	–	﹤0.01%	1655
2023 Q4	$17.5K	Hold	10,500	–	–	﹤0.01%	1612
2023 Q3	$32.5K	Hold	10,500	–	–	﹤0.01%	1432
2023 Q2	$29.9K	Hold	10,500	–	–	﹤0.01%	1476
2023 Q1	$41.4K	Hold	10,500	–	–	﹤0.01%	1386
2022 Q4	$41.6K	Hold	10,500	–	–	﹤0.01%	1494
2022 Q3	$96.5K	Hold	10,500	–	–	﹤0.01%	1327
2022 Q2	$64.6K	Hold	10,500	–	–	﹤0.01%	1465
2022 Q1	$67.4K	Hold	10,500	–	–	﹤0.01%	1502
2021 Q4	$68.8K	Hold	10,500	–	–	﹤0.01%	1501
2021 Q3	$60K	Hold	10,500	–	–	﹤0.01%	1549
2021 Q2	$57.8K	Sell	10,500 -100	-0.9%	-$567	﹤0.01%	1568
2021 Q1	$61.4K	Sell	10,600 -180	-2%	-$1.32K	﹤0.01%	1480
2020 Q4	$72.2K	Sell	10,780 -2,200	-17%	-$14.7K	﹤0.01%	1375
2020 Q3	$95K	Hold	12,980	–	–	﹤0.01%	1078
2020 Q2	$49.1K	Hold	12,980	–	–	﹤0.01%	1217
2020 Q1	$23.9K	Sell	12,980 -10,015	-44%	-$173K	﹤0.01%	1451
2019 Q4	$368K	Buy	22,995 +22,715	+8,113%	+$402K	0.01%	859
2019 Q3	$5.22K	Buy	280 +200	+250%	+$3.94K	﹤0.01%	1949
2019 Q2	$2.17K	Buy	+80	New	+$1.65K	﹤0.01%	2100

Other funds holding MIST

PCM

Pavaki Capital Management Pueblo, Colorado $287M AUM

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

PBM

Propel Bio Management Los Angeles, California $191M AUM 102.42% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

SAM

Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

KCM

Kalehua Capital Management Dallas, Texas $174M AUM

LPC

Lion Point Capital New York $20.9M AUM 195.52% 1-Year Est. Return

Federation des caisses Desjardins du Quebec's MIST Position: Q2 2026 in Review

Federation des caisses Desjardins du Quebec held its Milestone Pharmaceuticals (MIST) position steady in Q2 2026 at 29,781 shares worth $39.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1984.

Federation des caisses Desjardins du Quebec first reported a position in MIST in Q2 2019 and has held it in 29 quarters since. The position peaked at $368K in Q4 2019. 78 funds tracked by Wall St. Rank hold MIST as of Q2 2026.

Federation des caisses Desjardins du Quebec held 29,781 shares of Milestone Pharmaceuticals worth $39.9K as of Q2 2026.
Federation des caisses Desjardins du Quebec left its Milestone Pharmaceuticals share count unchanged in Q2 2026.
Milestone Pharmaceuticals made up ﹤0.01% of Federation des caisses Desjardins du Quebec's portfolio in Q2 2026, its #1984 holding.
Federation des caisses Desjardins du Quebec first reported a position in Milestone Pharmaceuticals in Q2 2019 and has held it in 29 quarters since.
Federation des caisses Desjardins du Quebec's Milestone Pharmaceuticals position peaked at $368K in Q4 2019.
78 funds tracked by Wall St. Rank held Milestone Pharmaceuticals as of Q2 2026.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q2 2026, filed 14 Aug 2026.